Hippo pathway and breast cancer stem cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Stem Cell Research

Background:

• Tumors harbor cancer stem-like cells (CSCs) responsible for therapeutic resistance and metastasis.
• The Hippo tumor suppressor pathway is implicated in breast cancer progression.
• Aberrant Hippo signaling or Hippo-independent mechanisms activate TAZ and YAP, promoting aggressive cancer traits.

Purpose of the Study:

• To review the role of TAZ and YAP in mammary gland development.
• To elucidate the involvement of TAZ and YAP in breast cancer stem cells (BCSCs).
• To explore clinical applications of TAZ/YAP pathway modulation.

Main Methods:

• Literature review focusing on the Hippo pathway, TAZ, YAP, and BCSCs.
• Analysis of molecular mechanisms linking TAZ/YAP activity to stemness and drug resistance.
• Synthesis of findings related to mammary gland development and breast cancer.

Main Results:

• TAZ and YAP activation is crucial for maintaining self-renewal and drug resistance in BCSCs.
• Improper TAZ/YAP activity contributes to metastatic dissemination.
• The Hippo pathway plays a significant role in both normal mammary development and breast cancer stem cell biology.

Conclusions:

• TAZ and YAP are key regulators of breast cancer stem cell properties.
• Targeting the TAZ/YAP axis presents a potential therapeutic strategy for breast cancer.
• Further research is needed to translate these findings into clinical practice.